{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:22:44Z","timestamp":1794036164926,"version":"4.8.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["607347"],"award-info":[{"award-number":["607347"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.vaccine.2019.09.071","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T09:35:10Z","timestamp":1570700110000},"page":"7233-7239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB)"],"prefix":"10.1016","volume":"37","author":[{"given":"Daniel","family":"Cowley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rini Mulia","family":"Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Handley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Novilia S.","family":"Bachtiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarir","family":"At Thobari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cahya Dewi","family":"Satria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Bogdanovic-Sakran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hera","family":"Nirwati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Orsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl D.","family":"Kirkwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yati","family":"Soenarto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5452-6601","authenticated-orcid":false,"given":"Julie E.","family":"Bines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vaccine.2019.09.071_b0005","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1473-3099(15)00227-3","article-title":"Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial","volume":"15","author":"Bines","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2019.09.071_b0010","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJMoa1706804","article-title":"Human neonatal rotavirus vaccine (RV3-BB) to target rotavirus from birth","volume":"378","author":"Bines","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.vaccine.2019.09.071_b0015","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/infdis\/jix186","article-title":"Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea","volume":"215","author":"Burnett","year":"2017","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2019.09.071_b0020","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.vaccine.2010.11.087","article-title":"Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries?","volume":"29","author":"Chan","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2019.09.071_b0025","doi-asserted-by":"crossref","first-page":"e00302","DOI":"10.1016\/j.heliyon.2017.e00302","article-title":"ROTAVAC((R)) does not interfere with the immune response to childhood vaccines in Indian infants: a randomized placebo controlled trial","volume":"3","author":"Chandola","year":"2017","journal-title":"Heliyon"},{"issue":"10","key":"10.1016\/j.vaccine.2019.09.071_b0030","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/INF.0b013e3181782780","article-title":"Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine","volume":"27","author":"Ciarlet","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"23","key":"10.1016\/j.vaccine.2019.09.071_b0035","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1016\/j.vaccine.2013.04.008","article-title":"Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine","volume":"31","author":"Danchin","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.071_b0040","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/cid\/civ807","article-title":"Interference of monovalent, bivalent, and trivalent oral poliovirus vaccines on monovalent rotavirus vaccine immunogenicity in rural Bangladesh","volume":"62","author":"Emperador","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.09.071_b0045","article-title":"The rotavirus vaccine development pipeline","author":"Kirkwood","year":"2017","journal-title":"Vaccine"},{"issue":"suppl_1","key":"10.1016\/j.vaccine.2019.09.071_b0050","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1093\/infdis\/jiw550","article-title":"A supply and demand management perspective on the accelerated global introductions of inactivated poliovirus vaccine in a constrained supply market","volume":"216","author":"Lewis","year":"2017","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.09.071_b0055","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1093\/cid\/civ1015","article-title":"Health impact of rotavirus vaccination in developing countries: progress and way forward","volume":"62","author":"Parashar","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.09.071_b0060","doi-asserted-by":"crossref","first-page":"A30","DOI":"10.1016\/j.vaccine.2011.11.093","article-title":"Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines","volume":"30","author":"Patel","year":"2012","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.09.071_b0065","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1093\/cid\/civ1205","article-title":"Sustained reduction of childhood Diarrhea-related mortality and hospitalizations in Mexico after rotavirus vaccine universalization","volume":"62","author":"Sanchez-Uribe","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.09.071_b0070","series-title":"Vaccine immunology","first-page":"16","author":"Siegrist","year":"2017"},{"issue":"39","key":"10.1016\/j.vaccine.2019.09.071_b0075","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1016\/j.vaccine.2008.08.034","article-title":"Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines","volume":"28","author":"Steele","year":"2010","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2019.09.071_b0080","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1097\/INF.0b013e3182138278","article-title":"Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America","volume":"30","author":"Tregnaghi","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.071_b0085","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/01.inf.0000199288.98370.71","article-title":"Neonatal administration of rhesus rotavirus tetravalent vaccine","volume":"25","author":"Vesikari","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.09.071_b0090","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1093\/infdis\/jiu060","article-title":"Switch from oral to inactivated poliovirus vaccine in Yogyakarta Province, Indonesia: summary of coverage, immunity, and environmental surveillance","volume":"210","author":"Wahjuhono","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.09.071_b0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4939-3292-4_8","article-title":"Standard Methods fpr detection of poliovirus antibodies","volume":"1387","author":"Weldon","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2019.09.071_b0100","unstructured":"WHO. Polio eradication & endgame strategic plan 2013\u20132018; 2013. Retrieved 28\/03\/2018, 2018, from http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/PEESP_EN_A4.pdf."},{"key":"10.1016\/j.vaccine.2019.09.071_b0105","unstructured":"WHO. Rotavirus vaccines; WHO position paper-January 2013; 2013, vol. 88. p. 49\u201364."},{"issue":"9","key":"10.1016\/j.vaccine.2019.09.071_b0110","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.vaccine.2008.12.059","article-title":"Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age","volume":"27","author":"Zaman","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1931299X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1931299X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:31:30Z","timestamp":1778679090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1931299X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":22,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0264410X1931299X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB)","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}